-
公开(公告)号:US20230183282A1
公开(公告)日:2023-06-15
申请号:US17995254
申请日:2021-04-01
发明人: Duxin Sun , Wei Gao , Hongxiang Hu , Mohamed Dit Mady Traore , Yudong Song , Bo Wen , Miao He , Hebao Yuan , Ruiting Li
CPC分类号: C07H7/06 , A61P31/12 , A61K9/127 , A61K9/5169
摘要: The present invention relates to methods, compounds, and compositions for treating viral infections, including COVID-19 viral infections. In certain embodiments, the compositions comprise: i) a remdesivir analog, ii) remdesivir or a remdesivir analog, and a surfactant, a cyclodextrin, or a combination thereof, iii) nanoparticles comprising albumin and remdesivir or remdesivir analog, iv) liposomes comprising lipids and remdesivir or remdesivir analog; and/or v) microparticles comprising PLA and/or PLGA, and remdesivir or remdesivir analog. In certain embodiments, the compositions are aqueous (e.g., for intravenous administration). In other embodiments, the compositions are nebulized or in the form of a dry powder (e.g., for inhalation by an infected subject).